OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
September 18, 2020
Data showed that empagliflozin with standard of care was superior to placebo in reducing the risk of CV death or hospitalization.
A study compared cardiac events associated with azithromycin versus amoxicillin.
September 10, 2020
The study investigators used artificial intelligence to analyze gut microbiome data in individuals with and without cardiovascular disease.
September 08, 2020
Approval was based on a phase 3 clinical trial comparing the investigative doses with the approved 1.5 mg dose.
September 03, 2020
There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to a major new study.
August 31, 2020
Dapagliflozin (Farxiga; AstraZeneca) demonstrated positive results in the phase 3 DAPA-CKD trial.
July 31, 2020
Empagliflozin (Jardiance; Eli Lilly) met the primary end point of a study for adults with heart failure with reduced ejection fraction with or without diabetes.
July 13, 2020
Azithromycin may be linked to a greater risk of cardiovascular death, according to a recent study.
July 03, 2020
A new study found increased plaque buildup levels in women with HIV who also suffered from persistent depression and stress.
July 02, 2020
Individuals recently diagnosed with type 2 diabetes were more likely to die from heart failure than any other cardiovascular disease, a study found.